SCHEMBL25166372

SCHEMBL25166372

CNc1nc(NCl)nc(NCCN2CCCCC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.42
PRMT6 Q96LA8 1/20 0.42
PRMT8 Q9NR22 1/20 0.42
LMNA P02545 2/20 0.40
TOP2A P11388 1/20 0.39
ACHE P22303 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
BACE1 P56817 1/20 0.39
PIM1 P11309 1/20 0.39
EGFR P00533 1/20 0.39
SIGMAR1 Q99720 2/20 0.39
KCNH2 Q12809 1/20 0.39
HTT P42858 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
APAF1 O14727 1/20 0.38
NPC1 O15118 1/20 0.38
NSD2 O96028 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24831524 0.82 PDE4A (0.44) CARM1PRMT6PRMT8LMNATOP2A
SCHEMBL24831589 0.81 KDM4E (0.44) CARM1PRMT6PRMT8LMNATOP2A
SCHEMBL25166631 0.81 HSD17B10 (0.43) CARM1PRMT6PRMT8LMNATOP2A
SCHEMBL24831511 0.79 KMT2A (0.44) CARM1PRMT6PRMT8LMNAMEN1
SCHEMBL1308939 0.79 LMNA (0.51) CARM1PRMT6PRMT8LMNATOP2A
SCHEMBL13406345 0.76 SIGMAR1 (0.45) LMNATOP2AACHESMN1; SMN2BACE1
SCHEMBL25166523 0.72 PGK1 (0.40) LMNASMN1; SMN2BACE1EGFR
SCHEMBL8468231 0.72 PIM1 (0.47) CARM1PRMT6PRMT8TOP2AACHE
SCHEMBL5032352 0.72 HTR1A (0.50) LMNAPIM1MEN1KMT2AKDM4E
SCHEMBL13243867 0.71 EGFR (0.61) LMNAACHEBACE1EGFRSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230123334-A1 AMINO LIPID COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shenzhen Shenxin Biotechnology Co., Ltd. (CN) 2023-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230123334-A1 AMINO LIPID COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF CETP, PLIN1, NOTUM CARM1 2798/4885PRMT6 790/4885PRMT8 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.